Breastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk

Chuanwu Zhu,Weiyong Liu,Hexiu Su,Sitong Li,Muhammad Adnan Shereen,Zhibao Lv,Zhili Niu,Dong Liu,Fang Liu,Zhen Luo,Yuchen Xia
DOI: https://doi.org/10.1016/j.jinf.2020.06.001
2020-01-01
Abstract:An emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) pandemic, imposes a great threat to global public health.1 The transmission and pathophysiology of SARS-CoV-2 gradually known among various populations, but public health effects of COVID-19 on women and their outcomes should not be ignored.1,2 In pregnant and perinatal women, vertical transmission of SARS-CoV-2 from an infected mother to her newborn is a controversial issue.2-4 SARS-CoV-2 was not detected in vaginal fluid from 10 women with COVID-195, however, no clear evidence regarding optimal delivery timing and safety of vaginal or cesarean delivery preventing SARS-CoV-2 vertical transmission has been reported.
What problem does this paper attempt to address?